Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 297

The DOI matches its Crossref record.

THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO

LIEBER, CHARLES S., DeCARLI, LEONORE M.·1972·The Journal of Pharmacology and Experimental Therapeutics

Abstract

To assess the in vivo role of the microsomal ethanol oxidizing system (MEOS) , an improved assay procedure was developed. When corrected for losses of microsomes during the preparation, the activity of MEOS in vitro corresponded to 20 to 25% of the in vivo rate of ethanol metabolism in the rat and could account for most of the residual ethanol metabolism after inhibition of alcohol dehydrogenase by pyrazole. Under these conditions, the apparent K m of MEOS in vitro coincided with the apparent K m of the blood ethanol disappearance in vivo . Furthermore, administration of ethanol to rats for 24 days increased blood ethanol clearance, with a parallel rise in MEOS activity, whereas the activities of alcohol dehydrogenase and catalase remained unchanged or decreased. Moreover, barbiturate treatment for four to five days also increased total MEOS activity in the liver and this was accompanied by a moderate acceleration of blood ethanol clearance. The latter effect was masked however if significant amounts of barbiturates were still present in the blood when ethanol was given. In addition. administration of one dose of barbiturate slowed blood ethanol clearance and abolished its increase induced by ethanol pretreatment, suggesting that barbiturates interfere with the metabolism of ethanol. In view of the parallel increase of blood ethanol clearance in vivo and MEOS activity in vitro after ethanol or barbiturate pretreatment, it is proposed that MEOS plays a significant role in vivo , a conclusion supported by the correspondence of the kinetic data of MEOS in vitro and of blood ethanol clearance after alcohol dehydrogenase inhibition in vivo .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)29204-7

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 297

Metadata

Authors
LIEBER, C. S., & DeCARLI, L. M.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1972-05
Volume
181
Issue
2
Pages
279-287
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2281513185
Cited by
297
References
0
FWCI
12.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO. https://app.cochat.ai/papers/10.1016/s0022-3565(25)29204-7
The paper
LIEBER, C. S., & DeCARLI, L. M. (1972). THE ROLE OF THE HEPATIC MICROSOMAL ETHANOL OXIDIZING SYSTEM (MEOS) FOR ETHANOL METABOLISM IN VIVO. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)29204-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.